Novel drug application shows improved survival for patients with relapsed and refractory acute myeloid leukemia

byOsaka Metropolitan UniversityEffect of the oral medication venetoclax after allogeneic hematopoietic cell transplantation. Credit: Osaka Metropolitan UniversityRelapsed/refractory acute myeloi

Updated on: August 01,2024 0

Novel drug application shows improved survival for patients with relapsed and refractory acute myeloid leukemia

byOsaka Metropolitan UniversityEffect of the oral medication venetoclax after allogeneic hematopoietic cell transplantation. Credit: Osaka Metropolitan UniversityRelapsed/refractory acute myeloi

Updated on:August 01,2024 0

Five amazing ways redesigning biological cells could help us fight cancer

by Chris Barnes,The ConversationCancer is the leading cause of death in the world. Credit: Julio C. Valencia, NCI Center for Cancer Research, CC BY-SACancer is theleading cause of death&nb

Updated on: April 07,2024 12

Five amazing ways redesigning biological cells could help us fight cancer

by Chris Barnes,The ConversationCancer is the leading cause of death in the world. Credit: Julio C. Valencia, NCI Center for Cancer Research, CC BY-SACancer is theleading cause of death&nb

Updated on:April 07,2024 12

Study identifies new potential treatment option for triple negative breast cancer

by Mayo ClinicCredit: Mayo ClinicIn a recent study published in theJournal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndro

Updated on: June 28,2024 3

Study identifies new potential treatment option for triple negative breast cancer

by Mayo ClinicCredit: Mayo ClinicIn a recent study published in theJournal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndro

Updated on:June 28,2024 3

Test can predict how people with leukaemia will respond to chemotherapy

by BloodwiseCredit: CC0 Public DomainThe first test to quickly and accurately predict how people will respond to standard treatment for the most common type of leukaemia has been developed at Cardiff

Updated on: April 18,2024 19

Test can predict how people with leukaemia will respond to chemotherapy

by BloodwiseCredit: CC0 Public DomainThe first test to quickly and accurately predict how people will respond to standard treatment for the most common type of leukaemia has been developed at Cardiff

Updated on:April 18,2024 19

Clinical trial shows rucaparib extends progression-free survival for uterine cancer patients

by Greg Glasgow,CU Anschutz Medical CampusCredit: CC0 Public DomainThe results of a multisite clinical trial overseen by University of Colorado Cancer Center member Bradley Corr, MD, could offer

Updated on: March 30,2024 0

Clinical trial shows rucaparib extends progression-free survival for uterine cancer patients

by Greg Glasgow,CU Anschutz Medical CampusCredit: CC0 Public DomainThe results of a multisite clinical trial overseen by University of Colorado Cancer Center member Bradley Corr, MD, could offer

Updated on:March 30,2024 0

Are 3-D mammograms really better? US puts scans to the test

by Lauran NeergaardIn this Nov. 21, 2017 photo provided by the Montefiore Health System, Dr. Tova Koenigsberg at The Montefiore Einstein Center for Cancer Care in New York shows an example of a tradit

Updated on: March 14,2024 13

Are 3-D mammograms really better? US puts scans to the test

by Lauran NeergaardIn this Nov. 21, 2017 photo provided by the Montefiore Health System, Dr. Tova Koenigsberg at The Montefiore Einstein Center for Cancer Care in New York shows an example of a tradit

Updated on:March 14,2024 13

Researchers develop method for separating tissue types in tumor samples

by University of North Carolina at Chapel Hill School of MedicineHematopoietic precursor cells: promyelocyte in the center, two metamyelocytes next to it and band cells from a bone marrow aspirat

Updated on: June 11,2024 5

Researchers develop method for separating tissue types in tumor samples

by University of North Carolina at Chapel Hill School of MedicineHematopoietic precursor cells: promyelocyte in the center, two metamyelocytes next to it and band cells from a bone marrow aspirat

Updated on:June 11,2024 5

Researchers develop tool to measure patient health and well-being after radionuclide therapy

by H. Lee Moffitt Cancer Center & Research InstituteGraphical abstract. Credit:Journal of Nuclear Medicine(2023). DOI: 10.2967/jnumed.122.264946Cancer is a devasting disease that

Updated on: February 03,2024 11

Researchers develop tool to measure patient health and well-being after radionuclide therapy

by H. Lee Moffitt Cancer Center & Research InstituteGraphical abstract. Credit:Journal of Nuclear Medicine(2023). DOI: 10.2967/jnumed.122.264946Cancer is a devasting disease that

Updated on:February 03,2024 11

Study compares the incidence of neuroendocrine neoplasms in China and the US

by Cactus CommunicationsNeuroendocrine neoplasms (NENs) are rare characterized by variable biology and delayed diagnosis. Researchers from China have now found disparities in the burden of NENs across

Updated on: January 16,2024 19

Study compares the incidence of neuroendocrine neoplasms in China and the US

by Cactus CommunicationsNeuroendocrine neoplasms (NENs) are rare characterized by variable biology and delayed diagnosis. Researchers from China have now found disparities in the burden of NENs across

Updated on:January 16,2024 19

ACO enrollment ups appropriateness of CA screening

(HealthDay)—Enrollment in the Medicare Shared Savings Program (MSSP) Accountable Care Organization (ACO) is associated with a reduction in breast cancer screening and an increase in colorectal cancer

Updated on: March 27,2024 18

ACO enrollment ups appropriateness of CA screening

(HealthDay)—Enrollment in the Medicare Shared Savings Program (MSSP) Accountable Care Organization (ACO) is associated with a reduction in breast cancer screening and an increase in colorectal cancer

Updated on:March 27,2024 18

Researchers set new bases to develop therapies against colorectal cancer

by IDIBELL-Bellvitge Biomedical Research InstituteDr. David G. Molleví and Dr. Natalia Guillén Díaz-Maroto, the group leader and first author of the study, respectively. Credit: Gemma FornonsRese

Updated on: June 04,2024 6

Researchers set new bases to develop therapies against colorectal cancer

by IDIBELL-Bellvitge Biomedical Research InstituteDr. David G. Molleví and Dr. Natalia Guillén Díaz-Maroto, the group leader and first author of the study, respectively. Credit: Gemma FornonsRese

Updated on:June 04,2024 6

Researchers identify a regulator of breast cancer development

by UT Southwestern Medical CenterBreast cancer stem cells (BCSCs) are responsible for breast carcinogenesis. Researchers' work reveals potential targets for killing BCSCs to prevent breast tu

Updated on: January 29,2024 14

Researchers identify a regulator of breast cancer development

by UT Southwestern Medical CenterBreast cancer stem cells (BCSCs) are responsible for breast carcinogenesis. Researchers' work reveals potential targets for killing BCSCs to prevent breast tu

Updated on:January 29,2024 14